Patent · US Active

IL12 receptor synthetic cytokines and methods of use

US12291572B2 · kind B2 · utility

0Cited by
7References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2021
Grant dateMay 6, 2025
Priority date
Expiry dateAug 5, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are IL12R binding molecules that bind to IL12Rb1 and IL12Rb2 and comprise an anti-IL12Rb2 sdAb and an anti-IL12Rb2 VHH antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.